Your browser doesn't support javascript.
loading
Palbociclib overcomes afatinib resistance in non-small cell lung cancer.
Nie, Huijuan; Zhou, Xiaoyan; Shuzhang, Du; Nie, Chunjie; Zhang, Xiaojian; Huang, Jianmin.
Affiliation
  • Nie H; Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: Longzhijian2008@126.com.
  • Zhou X; Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: 2512046850@qq.com.
  • Shuzhang D; Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: szduuu@163.com.
  • Nie C; Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: 1873232055@qq.com.
  • Zhang X; Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: zhxj0524@sina.com.
  • Huang J; Biological Cell Therapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: huangjianmin5625@163.com.
Biomed Pharmacother ; 109: 1750-1757, 2019 Jan.
Article in En | MEDLINE | ID: mdl-30551429

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyridines / Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Afatinib / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Biomed Pharmacother Year: 2019 Document type: Article Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyridines / Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Afatinib / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Biomed Pharmacother Year: 2019 Document type: Article Country of publication: France